Research Article
BibTex RIS Cite

EBEVEYNLERİN HPV AŞISI HAKKINDAKİ BİLGİ DÜZEYLERİ VE YAKLAŞIMLARI

Year 2019, Volume: 13 Issue: 2, 78 - 82, 26.03.2019
https://doi.org/10.12956/tchd.515713

Abstract

Amaç:



Human
Papilloma Virüs (HPV) serviks kanserinin en sık nedenidir. Serviks kanserini ve
HPV ilişkili diğer hastalıkları önlemede aşılama birincil olarak etkili
yöntemdir. Bu çalışmanın amacı ebeveynlerin HPV aşısı hakkındaki bilgi
düzeyleri ve yaklaşımlarını değerlendirmektir. 



Gereç ve Yöntemler:



Tanımlayıcı
olan bu çalışma Aralık 2018-Ocak 2019 tarihlerinde 9-18 yaş arası kız çocuğuna
sahip 203 ebeveyn üzerinde yapılmıştır. Ebeveynlerin demografik verileri, HPV
hakkındaki bilgileri ve HPV aşılamasına ilişkin tutumlarını içeren anketler
değerlendirildi.



Bulgular:



203
ebeveynin (% 80 anne ve% 20 baba)  yaş
ortalaması 39,1 ± 6,1 idi. Ebeveynlerin% 70'i HPV aşısını duymamıştı ve% 67'si
rahim ağzı kanserinin önlenebilir bir hastalık olduğunu bilmiyordu.
Ebeveynlerin% 62'si bilgilendirme sonrasında kızlarına HPV aşısını yaptırmayı
kabul etti. Aşının fiyatı ve doz sayısı hakkında bilgilendirme sonrasında,
ebeveynlerin% 24'ü 'Devlet tarafından ücretsiz karşılansa dahi yaptırmam'
şeklinde cevap verdi. En önemli nedenleri aşı hakkında yeterli bilgiye sahip
olmamaları idi (% 69).



Sonuç:



Çoğu ebeveyn HPV aşısını bilmemektedir ve bilgilendirme sonrası
çocuklarına aşı yaptırmayı kabul etmektedir. Bununla birlikte bazı ebeveynler,
ücretsiz karşılanmış olsa dahi çocuklarına aşı yaptırmayı düşünmemektedir.
Ailelerin bu konuda daha fazla aydınlatılması için sağlık çalışanlarına büyük
görev düşmektedir. 

References

  • Kaynaklar1. World Health Organisation. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. 2014.
  • 2. Wang Y-Q, Lu J-L, Liang Y-R, Li Q-S. Suppressive effects of egcg on cervical cancer. Molecules. 2018;23(9):2334.
  • 3. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nature Reviews Cancer. 2010;10(8):550-60.
  • 4. Azevedo J, Pista A, Lisboa C, Santo I, Azevedo L, Cunha M, et al. Epidemiology of human papillomavirus on anogenital warts in Portugal–The HERCOLES study. Journal of the European Academy of Dermatology and Venereology. 2017;31(8):1342-8.
  • 5. Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, et al. Efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomised, double-blind PATRICIA trial. Clinical and Vaccine Immunology. 2015;22(4):361-73.
  • 6. LaMontagne DS, Bloem PJ, Brotherton JM, Gallagher KE, Badiane O, Ndiaye C. Progress in HPV vaccination in low‐and lower‐middle‐income countries. International Journal of Gynecology & Obstetrics. 2017;138:7-14.
  • 7. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Methods. 1014;63(RR-05):1-30.
  • 8. Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Human vaccines & immunotherapeutics. 2019 Jan 11. doi: 10.1080/21645515.2018.1564436.
  • 9. Garland SM, Skinner SR, Brotherton JM. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Preventive medicine. 2011;53:29-35.
  • 10. Krawczyk A, Knäuper B, Gilca V, Dubé E, Perez S, Joyal-Desmarais K, et al. Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results. Human vaccines & immunotherapeutics. 2015;11(2):322-9.
  • 11. Bozkurt HB. Aşı Reddine Genel Bir Bakış ve Literatürün Gözden Geçirilmesi. Kafkas Tıp Bilimleri Dergisi. 2018;8(1):71-6.
  • 12. Viens LJ. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morbidity and mortality weekly report. 2016;65(26):661-6.
  • 13. Aslan E, Bektaş H, Başgöl Ş, Demir S, Vural PI. Üniversite öğrencilerinin cinsel sağlık konusundaki bilgi düzeyleri ve davranışları. STED. 2014;23(5):174-82.
  • 14. Grandahl M, Paek SC, Grisurapong S, Sherer P, Tydén T, Lundberg P. Parents’ knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand. PloS one. 2018;13(2):e0193054.
  • 15. Jaspers L, Budiningsih S, Wolterbeek R, Henderson F, Peters A. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine. 2011;29(44):7785-93.
  • 16. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. Journal of Adolescent Health. 2007;40(2):108-15.
  • 17. Lobao WM, Duarte FG, Burns JD, Santos CAdST, de Almeida MCC, Reingold A, et al. Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery? PloS one. 2018;13(11):e0206726.
  • 18. Salmon DA, Sotir MJ, Pan WK, Berg JL, Omer SB, Stokley S, et al. Parental vaccine refusal in Wisconsin: a case-control study. Wisconsin Medical Journal (WMJ). 2009;108(1):17-23.
Year 2019, Volume: 13 Issue: 2, 78 - 82, 26.03.2019
https://doi.org/10.12956/tchd.515713

Abstract

References

  • Kaynaklar1. World Health Organisation. Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. 2014.
  • 2. Wang Y-Q, Lu J-L, Liang Y-R, Li Q-S. Suppressive effects of egcg on cervical cancer. Molecules. 2018;23(9):2334.
  • 3. Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nature Reviews Cancer. 2010;10(8):550-60.
  • 4. Azevedo J, Pista A, Lisboa C, Santo I, Azevedo L, Cunha M, et al. Epidemiology of human papillomavirus on anogenital warts in Portugal–The HERCOLES study. Journal of the European Academy of Dermatology and Venereology. 2017;31(8):1342-8.
  • 5. Apter D, Wheeler CM, Paavonen J, Castellsagué X, Garland SM, Skinner SR, et al. Efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomised, double-blind PATRICIA trial. Clinical and Vaccine Immunology. 2015;22(4):361-73.
  • 6. LaMontagne DS, Bloem PJ, Brotherton JM, Gallagher KE, Badiane O, Ndiaye C. Progress in HPV vaccination in low‐and lower‐middle‐income countries. International Journal of Gynecology & Obstetrics. 2017;138:7-14.
  • 7. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Methods. 1014;63(RR-05):1-30.
  • 8. Karafillakis E, Simas C, Jarrett C, Verger P, Peretti-Watel P, Dib F, et al. HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe. Human vaccines & immunotherapeutics. 2019 Jan 11. doi: 10.1080/21645515.2018.1564436.
  • 9. Garland SM, Skinner SR, Brotherton JM. Adolescent and young adult HPV vaccination in Australia: achievements and challenges. Preventive medicine. 2011;53:29-35.
  • 10. Krawczyk A, Knäuper B, Gilca V, Dubé E, Perez S, Joyal-Desmarais K, et al. Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. Quantitative results. Human vaccines & immunotherapeutics. 2015;11(2):322-9.
  • 11. Bozkurt HB. Aşı Reddine Genel Bir Bakış ve Literatürün Gözden Geçirilmesi. Kafkas Tıp Bilimleri Dergisi. 2018;8(1):71-6.
  • 12. Viens LJ. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morbidity and mortality weekly report. 2016;65(26):661-6.
  • 13. Aslan E, Bektaş H, Başgöl Ş, Demir S, Vural PI. Üniversite öğrencilerinin cinsel sağlık konusundaki bilgi düzeyleri ve davranışları. STED. 2014;23(5):174-82.
  • 14. Grandahl M, Paek SC, Grisurapong S, Sherer P, Tydén T, Lundberg P. Parents’ knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand. PloS one. 2018;13(2):e0193054.
  • 15. Jaspers L, Budiningsih S, Wolterbeek R, Henderson F, Peters A. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine. 2011;29(44):7785-93.
  • 16. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. Journal of Adolescent Health. 2007;40(2):108-15.
  • 17. Lobao WM, Duarte FG, Burns JD, Santos CAdST, de Almeida MCC, Reingold A, et al. Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery? PloS one. 2018;13(11):e0206726.
  • 18. Salmon DA, Sotir MJ, Pan WK, Berg JL, Omer SB, Stokley S, et al. Parental vaccine refusal in Wisconsin: a case-control study. Wisconsin Medical Journal (WMJ). 2009;108(1):17-23.
There are 18 citations in total.

Details

Primary Language Turkish
Subjects ​Internal Diseases
Journal Section ORIGINAL ARTICLES
Authors

Esma Altınel Açoğlu 0000-0003-0333-6979

Melahat Melek Oğuz 0000-0002-4196-4469

Saliha Şenel 0000-0001-7203-5884

Publication Date March 26, 2019
Submission Date January 21, 2019
Published in Issue Year 2019 Volume: 13 Issue: 2

Cite

Vancouver Altınel Açoğlu E, Oğuz MM, Şenel S. EBEVEYNLERİN HPV AŞISI HAKKINDAKİ BİLGİ DÜZEYLERİ VE YAKLAŞIMLARI. Türkiye Çocuk Hast Derg. 2019;13(2):78-82.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.